Biogen shares are trading lower after the company reported Q3 financial results and issued weak FY23 guidance.
Portfolio Pulse from Benzinga Newsdesk
Biogen reported its Q3 financial results and issued a weak forecast for FY23, leading to a drop in its share price.
November 08, 2023 | 3:33 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Biogen's shares are trading lower due to disappointing Q3 results and weak FY23 guidance.
Biogen's Q3 financial results were below expectations and the company's FY23 guidance was weak. This negative news directly impacts the company's stock price, causing it to trade lower.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100